World Health Organization member governments have been working for several years to agree on ways to prevent the spread of dangerous and misleading substandard and fake medical products. Now, they seem to be moving in the direction of concrete action.  

CAPE TOWN, SOUTH AFRICA – Public groups this week urged Mark Dybul, head of the Geneva-based Global Fund for HIV, Tuberculosis and Malaria, to reconsider the establishment of a panel to look at tiered pricing for middle income countries, potentially allowing companies to charge them higher prices. And separately, activists reported on progress in South Africa’s HIV strategy.

Ten global health organisations today launched “Fight the Fakes,” a global campaign against “fake” medicines, aimed at raising awareness about medicines – brand or generic – that are not what they claim to be. Meanwhile, a Swiss pharmaceutical company official was named head of investigations at a top international public health organisation.

The World Health Organization, the United Nations health agency in persistent financial straits, has announced it must begin charging a fee to manufacturers seeking prequalification of their vaccines and diagnostics. The announcement stirred concern among public health advocates that it might have a negative effect for procurement and access to life-saving medicines.

The heads of state of the African Union (AU), the regional body working on African integration, have decided to proceed with the establishment of a Pan-African Intellectual Property Office (PAIPO), despite misgivings about the potential impact on their local economies.